{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:18:15Z","timestamp":1761488295061},"reference-count":20,"publisher":"Baishideng Publishing Group Inc.","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.3694","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T05:44:15Z","timestamp":1249451055000},"page":"3694","source":"Crossref","is-referenced-by-count":6,"title":["Bell\u2019s palsy and choreiform movements during peginterferon \u03b1 and ribavirin therapy"],"prefix":"10.3748","volume":"15","author":[{"given":"Sener","family":"Barut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Karaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"Oksuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asl\u0131 G\u00fcndo\u011fdu","family":"Eken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Nazl\u0131","family":"Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Vial T, Choquet-Kastylevsky G, Liautard C, Descotes J. Endocrine and neurological adverse effects of the therapeutic interferons. Toxicology 2000;142:161-172.","DOI":"10.1016\/S0300-483X(99)00141-9"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-147.","DOI":"10.1177\/019459988509300202"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Morgan M, Nathwani D. Facial palsy and infection: the unfolding story. Clin Infect Dis 1992;14:263-271.","DOI":"10.1093\/clinids\/14.1.263"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Bleicher JN, Hamiel S, Gengler JS, Antimarino J. A survey of facial paralysis: etiology and incidence. Ear Nose Throat J 1996;75:355-358.","DOI":"10.1177\/014556139607500608"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Hoare M, Woodall T, Alexander GJ. Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res 2005;25:174-176.","DOI":"10.1089\/jir.2005.25.174"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.","DOI":"10.1016\/S0168-8278(96)80184-X"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, Nishioji K, Katagishi T, Nakagawa Y, Tada H. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-291.","DOI":"10.1016\/S0168-8278(96)80113-9"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Chutaputti A. Adverse effects and other safety aspects of the hepatitis C antivirals. J Gastroenterol Hepatol 2000;15 Suppl:E156-E163.","DOI":"10.1046\/j.1440-1746.2000.02114.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A. Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C. Aliment Pharmacol Ther 2002;16:1633-1639.","DOI":"10.1046\/j.1365-2036.2002.01331.x"},{"key":"ref10","unstructured":"Lee MY, Cho H, Kim YM, Lee JS. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection]. Korean J Hepatol 2006;12:444-448."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ogundipe O, Smith M. Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders. Haemophilia 2000;6:110-112.","DOI":"10.1046\/j.1365-2516.2000.00391.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Hwang I, Calvit TB, Cash BD, Holtzmuller KC. Bell's palsy: a rare complication of interferon therapy for hepatitis C. Dig Dis Sci 2004;49:619-620.","DOI":"10.1023\/B:DDAS.0000026389.56819.0c"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Cramp ME, Rossol S, Chokshi S, Carucci P, Williams R, Naoumov NV. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 2000;118:346-355.","DOI":"10.1016\/S0016-5085(00)70217-4"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Abramsky O, Webb C, Teitelbaum D, Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell's palsy). J Neurol Sci 1975;26:13-20.","DOI":"10.1016\/0022-510X(75)90109-4"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Hayasaka S, Fujii M, Yamamoto Y, Noda S, Kurome H, Sasaki M. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995;79:150-152.","DOI":"10.1136\/bjo.79.2.150"},{"key":"ref16","unstructured":"Kawano T, Shigehira M, Uto H, Nakama T, Kato J, Hayashi K, Maruyama T, Kuribayashi T, Chuman T, Futami T. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 1996;91:309-313."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Moulignier A, Allo S, Zittoun R, Gout O. Recombinant interferon-alpha-induced chorea and frontal subcortical dementia. Neurology 2002;58:328-330.","DOI":"10.1212\/WNL.58.2.328"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Yoshikubo S, Kimura K, Mizuashi K, Kamo S, Maeda K, Kobatake S. [A case of chorea-like movement induced during interferon treatment of chronic hepatitis C]. Nippon Naika Gakkai Zasshi 1997;86:1036-1038.","DOI":"10.2169\/naika.86.1036"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Neau JP, Guilhot F, Boinot C, Dumas P, Tantot AM, Gil R. Development of chorea with lupus anticoagulant after interferon therapy. Eur Neurol 1996;36:235-236.","DOI":"10.1159\/000117257"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Brito MO, Doyle T. Movement and extrapyramidal disorders associated with interferon use in HIV\/hepatitis C coinfection. AIDS 2007;21:1987-1989.","DOI":"10.1097\/QAD.0b013e32829fb369"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i29\/3694.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:23:25Z","timestamp":1558473805000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i29\/3694.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":20,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.3694","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}